Transcriptome profiling is widely used to infer functional states of specific cell types, as well as their responses to stimuli, to define contributions to physiology and pathophysiology. Focusing on microglia, the brain's macrophages, we report here a side-by-side comparison of classical cell-sorting-based transcriptome sequencing and the 'RiboTag' method, which avoids cell retrieval from tissue context and yields translatome sequencing information. Conventional whole-cell microglial transcriptomes were found to be significantly tainted by artifacts introduced by tissue dissociation, cargo contamination and transcripts sequestered from ribosomes. Conversely, our data highlight the added value of RiboTag profiling for assessing the lineage accuracy of Cre recombinase expression in transgenic mice. Collectively, this study indicates method-based biases, reveals observer effects and establishes RiboTag-based translatome profiling as a valuable complement to standard sorting-based profiling strategies.
C ellular functions are defined by transcriptomes and proteomes. Global gene expression profiling can hence provide insights into specific contributions of distinct cell types to various physiological processes. Macrophages are myeloid immune cells that are strategically positioned to ingest and degrade dead cells, debris and foreign material and to orchestrate inflammation and immune defense. Moreover, emerging evidence supports additional critical tissue macrophage contributions to the establishment and maintenance of organ functions. Studies have highlighted the impact of the tissue environment on macrophage expression signatures and enhancer landscapes 1, 2 . Conversely, tissue macrophages lose distinct expression patterns once taken into culture 2 , likely as a result of the loss of original environmental cues and exposure to new ones. Accurate expression profiling of cells to infer in vivo functions therefore requires methods that allow efficient and rapid retrieval of phenotypically specified cells or their RNA from intact organs.
Classically, the isolation of defined cell populations from their physiological tissue context involves the preparation of single-cell suspensions followed by flow-cytometry-or magnetic-bead-based cell sorting. Depending on the cell type studied and its respective extent of tissue embedding, release of the cells can require mechanical processing and extensive enzymatic digestion with prolonged incubations. Collectively, these manipulations confer the inherent risk of artifacts. Moreover, cell isolation protocols are often inefficient and prone to introduce bias toward subpopulations. Even optimized isolation protocols fail, for instance, to retrieve more than 10% of microglia cells from an intact mouse brain, estimated to comprise 3 million cells.
To circumvent the need for cell retrieval, alternative approaches were introduced that allow isolation of cell-specific translatomes by immunoprecipitation (IP) of epitope-tagged ribosomes from crude tissue extracts 3, 4 . In the RiboTag approach developed by McKnight and colleagues 4 , cell-type-specific expression of Cre recombinase is used to activate expression of a hemagglutinin (HA) epitope-tagged ribosomal subunit (RPL22) by deletion of a loxP-flanked (floxed) wild-type exon. IP of the tagged ribosomes from whole tissue extracts with anti-HA antibody-coupled magnetic beads enables the pulldown of cell-type-specific ribosome-attached mRNA; i.e., the translatome.
Here we report the application of the RiboTag approach to the study of microglia. Specifically, we compared previously reported Cx3cr1 Cre and Cx3cr1 CreER transgenic animals 5 for their potency and specificity to be used in microglial expression profiling using the RiboTag strategy. Side-by-side comparison of translatomes isolated by IP from crude tissue extracts and transcriptomes from sorted microglial cells highlights the advantages and disadvantages of the respective approaches. Whole-cell transcriptomes were found to be contaminated by artifacts induced by tissue dissociation, contamination with cargo and transcripts sequestered away from ribosomes. Finally, we performed a translatome analysis on microglia from animals exposed to acute peripheral endotoxin challenge. Collectively, our results highlight the specifics of RiboTag profiling and establish this method as a valuable complement to standard sorting-based profiling strategies.
Results
Definition of cell type specificity of CX3CR1 Cre and CX3CR1 CreER transgenic mice. The RiboTag strategy is a two-component approach relying on the combination of a floxed Rpl22 HA allele 4 with a cell-type-specific Cre recombinase transgene. Microglia display unique high expression of CX 3 CR1 6 , and transgenic mice harboring a GFP reporter gene under the promoter of this chemokine receptor have been instrumental in studying microglial morphology and dynamics, as GFP expression in adult mouse brains is restricted to microglia and non-parenchymal macrophages 6, 7 . More recently, we
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introduced two mouse strains that display Cre recombinase activity under the control of the Cx3cr1 promoter, either constitutively (Cx3cr1 Cre mice) or following tamoxifen (TAM)-mediated activation of an estrogen receptor-fused latent Cre recombinase (Cx3cr1 CreER mice) 5, 8 (Fig. 1a ). To implement the RiboTag method for the study of microglia, we generated Cx3cr1 Cre :Rpl22 HA and Cx3cr1 CreER :Rpl22 HA mice, all homozygous for the Rpl22 HA allele. We then performed high-throughput RNA sequencing (RNA-seq) on RNA isolated from whole brain tissue (input), RNA retrieved by an isotype control IP (IP-IgG) and RNA retrieved by anti-HA IP (IP-HA) of brain extracts from the two mouse strains ( Fig. 1b) . To assess the cell type specificity of the obtained translatomes, we compared them to published neuron-and glia-specific gene expression signatures 9 . Translatomes retrieved from Cx3cr1 Cre :Rpl22 HA and TAM-treated Cx3cr1 CreER :Rpl22 HA mice showed an enrichment for mRNAs encoding microglial proteins, such as Sall1, Csf1r, Trem2, Aif1 (Iba-1) and CD11b, which represent a small fraction in the total input, confirming rearrangement of the floxed Rpl22 HA allele in microglia ( Fig. 1c ). Conversely, key astrocyte and oligodendrocyte transcripts, such as Gfap, Aldh1l1, Aqp4 and Mbp, Mog, Olig1, Plp1, respectively, were de-enriched in both translatomes as expected ( Fig. 1c ). Translatomes retrieved by ribosome IP from brain homogenates of Cx3cr1 Cre :Rpl22 HA but not TAM-treated Cx3cr1 CreER :Rpl22 HA mice also exhibited a prominent neuronal signature, including mRNAs encoding calbindin 2, CX 3 CL1 and CELF ( Fig. 1c and Supplementary  Fig. 1 ). This suggested activation of RPL22-HA expression in neuronal cells of Cx3cr1 Cre :Rpl22 HA mice. Analysis of Cx3cr1 Cre :Rosa26 YFP animals, which harbor a floxed reporter allele, revealed prominent neuronal labeling, comparable to that recently reported for LysM Cre mice 10 ( Fig. 1d and Supplementary Fig. 2a ). Moreover, immunohistochemical analysis of Cx3cr1 Cre :Rpl22 HA animals detected neuronal staining by anti-HA antibodies in spinal cord and brain sections, including in Purkinje cells in the cerebellum, in line with the observed Calb2 expression ( Fig. 1e and Supplementary Fig. 2b ). In contrast, RPL22-HA expression in TAM-treated Cx3cr1 CreER :Rpl22 HA mice was restricted to microglia, as demonstrated by co-staining for IBA-1 ( Fig. 1e and Supplementary Fig. 2b ). Since Cx3cr1 gfp mice lack GFP labeling in adult neurons 6, 11 , rearrangements in Cx3cr1 Cre mice are likely due to a transient and yet-to-be-defined window of Cx3cr1 promoter activity during neuronal development. In support of this notion, one of the Cx3cr1 Cre :Rpl22 HA mice analyzed also displayed astrocyte and oligodendrocyte transcripts, in line with the shared neuroectodermal origin of these glia cells and neurons ( Fig. 1c ). Of note, rearrangements in neurons of Cx3cr1 Cre :Rpl22 HA animals were observed irrespective of whether the floxed allele and the Cre transgene went together through the germline (data not shown).
Cx3cr1 CreER :Rpl22 HA mice that were TAM-treated postnatally displayed brain macrophage-restricted activation of the RiboTag. Some enrichment for the microglia translatome was also observed without TAM treatment in these mice, and rare YFP + cells could be detected in untreated Cx3cr1 CreER :Rosa26 YFP animals ( Fig. 1c ,d middle panel), corroborating reports of leakiness of the CreER system 12 . However, as confirmed by flow cytometric analysis ( Fig. 1f ), robust rearrangement and microglial expression of the HA epitope-tagged ribosome subunit in Cx3cr1 CreER :Rpl22 HA mice were dependent on TAM induction in our facility. Collectively, these data illustrate the value of the RiboTag profiling approach for assessing the accuracy of Cre transgenic mouse models and investigating specific cell types, including fate mapping and conditional mutagenesis.
Comparison of RiboTag profiling to cell-sorting-based transcriptomics.
Having established the value of Cx3cr1 CreER :Rpl22 HA mice, we next compared translatomes and transcriptomes of sorted and unsorted microglia. Specifically, we divided individual brains of TAM-treated Cx3cr1 CreER :Rpl22 HA mice: one hemisphere underwent direct tissue homogenization followed by IP-HA or an IP-IgG control to define the method-related background. The second hemisphere was subjected to the classical microglia isolation protocol involving tissue digestion followed by cell sorting of microglial cells (defined as DAPI -Ly6C/G (Gr1) -CD11b + CD45 int ) ( Fig. 2a and Supplementary Fig. 3 ). A fraction of the sorted microglia was taken for direct mRNA isolation to yield the whole transcriptome (Sort); another fraction was lysed and subjected to IP-HA to retrieve the translatome of sorted cells (Sort-IP) ( Fig. 2a ). This experimental setup allowed comparison of translatomes of sorted and unsorted microglia alongside whole transcriptomes of sorted microglia from the same brain, and thus investigation of the impact of the isolation protocol on gene expression.
Unbiased k-means clustering of the significantly differentially expressed genes between at least two sample groups (IP-HA vs. IP-IgG, IP-HA vs. Sort, IP-HA vs. Sort-IP and Sort vs. Sort-IP, fold change > 2, P < 0.05) revealed 2,508 differentially expressed genes, which could be divided into four clusters ( Fig. 2b ). Cluster IV was discerned as RiboTag method-related background, since mRNA reads in the nonspecific IP-IgG were higher than in the specific IP-HA and absent from sorted samples. IP-specific genes were selected for being significantly higher in IP-HA than IP-IgG (fold change > 2, P < 0.05), and all genes below this threshold were removed from the analysis. Cluster I comprised 913 mRNAs enriched in the specific IP-HA compared with IP-IgG and present in both samples of sorted microglia. This cluster includes established microglia signature genes, such as Aif1, Irf8, Sall1, Cx3cr1, Tgfbr, Tmem119 and Hexb ( Fig. 2b and Supplementary Fig. 4 ), indicating that the retrieval methods we used are comparable. Cluster II was represented by 525 mRNAs that were highly abundant in sorted samples (both in translatome and transcriptome) but not present in the direct IP-HA. Cluster III comprised 282 mRNAs prominently enriched in the direct IP-HA, but less abundant in the sorted microglia. Clusters II and III highlight differences between the retrieval methods, as well as discrepancies between transcriptomes and translatomes, and will be the focus of the remainder of this study.
Transcripts over-represented in microglia translatomes. Cluster III (Fig. 2b) is defined by genes highly expressed in IP-HA samples relative to Sort samples and could be further subdivided according to transcript abundance in the Sort-IP samples ( Fig. 2c) : cluster III-a (72 mRNAs) were low in both samples of the sorted cells (Sort and Sort-IP); clusters III-b and III-c (210 mRNAs) were low in the Sort samples but highly expressed in the Sort-IP samples ( Fig. 2c) .
Cluster III-a can be largely explained by the presence of nonparenchymal macrophage mRNAs. Non-parenchymal brain macrophages, including perivascular, meningeal and choroid plexus macrophages, can be discriminated from CD11b + CD45 int microglia as CD11b + CD45 hi cells and therefore excluded by fluorescence-activated cell sorting ( Fig. 2d ). CX 3 CR1 is expressed both in microglia and in non-parenchymal brain macrophages ( Fig. 2d) 13 . Accordingly, both CD45 int microglia and CD45 hi macrophages of TAM-treated Cx3cr1 CreER :Rpl22 HA mice express the HA-tagged Rpl22 isoform ( Fig. 2e ). Moreover, some of the non-parenchymal brain macrophages are long-lived like microglia and hence the population does not lose the rearranged alleles as monocytes do 13 . Single-cell transcriptomics have shown that non-parenchymal brain macrophages differ in gene expression from microglia 13, 14 . Accordingly, cluster III-a included Cd163, F13a1, Cbr2, Mrc1 and Lyve1 (Fig. 2f,g) .
The combined clusters III-b and III-c comprise mRNAs that are enriched in both IP-HA and Sort-IP translatomes over the whole transcriptomes, suggesting their functional importance for the cells. These include mRNAs encoding proteins related to metabolism (Gpx1, Sdhc), vesicular transport (Clta, Kdelr1, Ykt6), sphingolipid metabolism (Gm2a, Psap) and lipids (Apoe), as well as components of the GABA-receptor signaling cascade (Gabarap, Gnai2) ( Fig. 2h ). Specific functions of these genes in microglia remain to be explored.
Collectively, these results highlight the value of a multifaceted approach, combining the RiboTag and cell sorting strategies to improve cell type specificity. In addition, the RiboTag approach allows us to focus specifically on genes that are actively being translated and contributing to the cellular proteome at a particular time and location.
Transcripts over-represented in transcriptome cluster I: isolation artifacts. Cluster II (Fig. 2b) consists of 525 mRNAs that were high in Sort but low in IP-HA. This cluster can be further subdivided according to transcript abundance in the Sort-IP samples (Fig. 3a) . Cluster II-a comprised 190 transcripts similarly expressed in Sort-IP and Sort samples and was found to include mRNAs that are related to immune activation, such as Cd86, Cd53, Tlr4, and Tlr7 (Fig. 3b ). Ingenuity pathway analysis (IPA) of significantly upregulated genes in Sort vs. IP-HA (fold change > 2, P < 0.05) showed upregulation of pathways such as "Production of NOS and ROS, " "Phagocytosis" and "TLR signaling" (Fig. 3c ).
Since these transcripts are high in both translatomes and transcriptomes of sorted cells, we assume that they reflect cell activation resulting from the isolation process, as recently reported from another system 15 . Commonly used macrophage isolation protocols, such as the one we applied for the microglia retrieval, include enzymatic tissue digestion at 37 °C, a step that could cause cell activation and transcriptome alterations. Moreover, enzymes employed in these digests might contain endotoxin contaminations that could activate cells. To probe for the potential impact of these manipulations, we compared transcriptomes of sorted cells that were isolated from the same brain with or without collagenase and DNase digestion, as well as the RiboTag approach. Surprisingly, though, both isolation procedures resulted in comparable transcriptional profiles, indicated by differential expression of 472 and 267 genes (clusters II and III, respectively), as compared to the relevant IP samples ( Supplementary Fig. 5a ). Global correlation of gene expression of the samples retrieved with or without incubation was high (r 2 = 0.99), as compared to the correlation of sorted and IP samples (r 2 = 0.1) ( Supplementary Fig. 5b ). Similarities were also apparent in a correlation matrix compiled from data of independent experiments ( Supplementary Fig. 5c ). Collectively, these data establish that the artifact is reproducible and suggest that it is introduced by extraction of the cells from their native environment, rather than subsequent manipulation.
Transcripts over-represented in the transcriptome cluster II: cargo contaminants and sequestered RNAs. Cluster II-b spanned 335 genes that were low in the Sort-IP compared with Sort samples ( Fig. 3a ), suggesting translatome-transcriptome differences.
Microglia are specialized phagocytes that, like other macrophages, take up dead cells and cell debris for clearance 16 . Although we did not formally rule out other sources of contamination, whole-cell transcriptomes could hence include genetic material from recently ingested neighboring cells. Indeed, almost half of the mRNAs in cluster II-b (157 out of 335 genes) were likely to be derived from such external sources (Fig. 4a ). Examples include Arhgap5, Son and Pisd-ps1, which are reportedly transcribed in astrocytes and neurons 9 (Fig. 4b ).
Long noncoding mRNAs (lncRNAs) are enriched in nuclei 17 , where some of them act in transcriptional regulation. As expected, representatives of these lncRNAs, such as Malat1 and Neat1, were identified in the whole cell transcriptomes, while absent from translatomes, and appeared in cluster II-b (Fig. 4c) .
Gene expression is controlled at the level of transcription and translation. The latter comprises specific mechanisms that prevent mRNAs from their integration into ribosomes, including nuclear retention and sequestration into dedicated membraneless cytosolic ribonucleoprotein complexes 18, 19 . The content of these organelles, such as processing bodies (P-bodies) and stress granules, is only beginning to be defined 19, 20 . However, sequestered mRNAs have been reported to be longer and to comprise extended 3′ untranslated regions (UTRs), as well as to display lower splicing efficiencies 19, 21 . When analyzed for these three parameters, mRNAs defined by cluster II-b showed significant presence of these hallmarks, as compared to all other clusters (Fig. 4d) . Moreover, transcripts of cluster II-b also showed significant overlap with the list of nuclear retained mRNAs reported for other cellular systems 22 (Fig. 4e ). Among the protein-coding mRNAs that seem sequestered from immediate translation, we found Fos, Jun, Egr1 and Zfp36l1 (Fig. 4f) , which are immediate-early genes that have been described to be induced within minutes after activation. Of note, these mRNAs appear also in the translatome of the sorted cells, suggesting that they move to the ribosomes during the isolation procedure. Collectively, the discrepancies we observed between microglia translatomes and whole-cell transcriptomes can be explained by the inclusion of cargo-derived transcripts and mRNAs sequestered to nuclei or P-bodies (Fig. 4g) . These data highlight the value of the RiboTag approach for retrieving functionally relevant mRNAs.
RiboTag analysis of microglial response to peripheral LPS challenge.
Arguably, method-related artifacts, such as the ones associated with microglia isolation, could be neutralized if controls and experimental samples were prepared using the same approach. However, this assumes that artifacts introduced by the isolation are not affected by biological treatments and challenges. To examine this issue, we performed the RiboTag protocol on TAMtreated Cx3cr1 CreER :Rpl22 HA mice following an intraperitoneal lipopolysaccharide (LPS) injection (2.5 mg/kg). Brain hemispheres of individual LPS-and PBS-treated animals were subjected to either homogenization or microglial isolation and sorting, and processed ( Fig. 2a ) and used to generate a summary heat map of the RNA-seq data ( Supplementary Fig. 6 ). To define the effect of the isolation method on microglia of LPS-treated and PBS-treated mice, we performed separate analyses for differentially expressed genes between PBS and LPS treatment in each method and then assessed the respective overlap. The majority of genes detected as up-or downregulated by the endotoxin challenge in the IP sample were shared with the sorted samples (Fig. 5a,c) . Mutual genes correlated between methods and showed a similar trend of up and downregulation ( Fig. 5b,d) , indicating that bona fide LPS-induced changes are seen with both methods. Upregulated genes included Il4ra, Ch25h and Il1b (Fig. 5b) , while microglial signature genes such as Tgfbr1, Sall1 and Cx3cr1 were downregulated (Fig. 5d) .
Notably, a considerable number of mRNAs changed upon LPS treatment only in the sorted samples, but not in the anti-HA IP from whole-brain extract (46% of the upregulated and 71% of the downregulated genes) (Fig. 5a,c) . Transcripts that were detected as changed upon LPS treatment in sorted samples (both Sort and Sort-IP) but not in IP-HA included genes related to immune activation such as Il1a, Ccl2 and Vcam1 that were upregulated ( Fig. 5e) and Tlr4, Siglech and Cd48 that were downregulated (Fig. 5e ). Since they were found in the Sort-IP samples as well, these mRNAs are likely translated in sorted but not in unsorted microglia. These data establish that the artifact introduced by the cell isolation is affected by the state of the animals from which the cells are retrieved. Moreover, mRNAs that are defined as cargo contamination, owing to their presence in the transcriptomes but absence from IPs of the sorted cells, changed following the LPS challenge ( Fig. 5f ). For example Pisd-ps1, Arhgap5 and Tia1 were downregulated and Ranbp2, Tet2 and Gas5 were upregulated upon LPS challenge (Fig. 5f ). All of these genes were reported to be more highly expressed by other brain cells, rather than microglia ( Supplementary Fig. 7 ) 9 , and are absent from the translatomes of either sorted or unsorted microglia in our dataset.
Collectively, these results indicate that data retrieved from sorted microglia include false information that originates from sortingrelated immune activation and cargo contamination from ingested cells. Importantly, our data establish that identical processing of control and test samples does not necessarily neutralize these artifacts, since they themselves are affected by the biological treatment. Taking these findings together, our study highlights the advantages and disadvantages of classical sorting-based cell isolation protocols and the RiboTag approach (Supplementary Table 1 ).
Discussion
Here we compared experimental approaches for retrieving microglial expression signatures from brains of untreated and challenged animals. Specifically, we defined strengths and weaknesses of the classical cell isolation and sorting-based protocols and the RiboTag strategy 4 , which relies on polyribosome IP from crude tissue extracts. Below we discuss the pros and cons of the respective techniques.
The RiboTag strategy was originally introduced by McKnight and colleagues and applied to expression profiling of neurons and Sertoli cells 4 . Cell type specificity of the approach depends on the accuracy of the Cre driver that is combined with the Rpl22 HA allele. This aspect is highlighted in our study by the side-by-side comparison of Cx3cr1 Cre and Cx3cr1 CreER animals, which revealed the superiority of the inducible system for achieving brain macrophage specificity and excluding neurons. However, as reported earlier and confirmed in this study, even Cx3cr1 CreER mice target not only microglia, but also non-parenchymal macrophages 13 . In situations where subpopulations can be phenotypically discriminated, as in the case of CD45 int microglia and CD45 hi perivascular macrophages, sorting-based approaches, potentially combined with a RiboTag analysis as in this study, can hence be advantageous. This emphasizes the need for the development of new Cre transgenic lines targeting microglia, including combinatorial approaches, such as the split-Cre strategy 23 , to improve the cell-type or lineage specificity. Importantly, current tests for accuracy of Cre transgenic lines are based on their combination with reporter alleles and the analysis of resulting double transgenic animals by flow cytometry.
As in the case of Cx3cr1 Cre animals reported here, or LysM Cre mice, in which expression was assumed to be myeloid cell-specific but found to also target neurons 10 , this approach is insufficient. Our results demonstrate that the RiboTag approach provides a useful complementary method of determining Cre line specificity, in particular for cell types such as neurons and endothelial cells that are notoriously difficult to isolate for flow cytometric analysis.
Macrophage expression signatures tend to be contaminated by material the phagocytes ingested from their surroundings. Since the RiboTag strategy retrieves only mRNAs that are associated with HA-epitope-tagged host cell ribosomes, it excludes such exogenous material and hence allows identification of bona fide macrophage mRNAs.
Although not directly addressed in this study, an additional benefit of the RiboTag approach is the fact that it can be used to determine the effect of conditional mutations. Specifically, Cre-mediated rearrangements result in parallel mutagenesis and induction of the Rpl22 HA allele. For instance this approach was used to define the impact of an Mecp2 deficiency on macrophages in brown adipose tissue (BAT), comparing translatomes retrieved from BAT of Cx3cr1 CreER :Rpl22 HA and Cx3cr1 CreER :Rpl22 HA :Mecp2 fl/y mice 24 .
Ribosome-associated mRNAs, as retrieved by the RiboTag approach, are considered to reflect the translatome. Notably, though, the microglial response to LPS using an analogous experimental system showed that mRNAs induced by the challenge can be prevented from translation by binding of a splicing factor to their 3′ UTRs 25 . Like other emerging layers of post-transcriptional expression control, this mechanism, which was revealed by a combined transcriptome and peptidome analysis on immunoprecipitated ribosomes, requires further study.
Above we listed advantages of the RiboTag approach, but an inherent weakness of this protocol is its reliance, for confident assessment of gene expression in the targeted population, on an enrichment of the specific mRNA over the input; i.e., the wholetissue extract. The RiboTag approach hence precludes statements about the expression of genes that are equally expressed in the target cells and the surrounding tissue. For the assessment of these coexpressed genes, sorting-based strategies might be superior, although these also bear caveats, as outlined below.
Side-by-side comparison of the translatomes isolated by IP from crude tissue extracts and from sorted microglial cells with wholecell transcriptomes revealed shortcomings of the latter. First, we noted a prominent activation signature that is presumably introduced during the process of extracting cell from their tissue context. This artifact comprised proinflammatory genes, such as Cd86, Tlr4 and Tlr7, and will have to be considered in microglia profiling studies. Importantly, this robust and reproducible artifact could not be discerned when control and test samples were processed similarly. Rather, we found that the isolation procedure had a differential impact on microglia retrieved from either challenged or unchallenged animals. Of note, artifacts such as the ones we report here that are introduced during the isolation procedure were shown to be significantly reduced when the transcription inhibitor actinomycin D was included during cell preparation 26 .
Taken together, our study shows that cell isolation coupled with sorting-based methods and the RiboTag approach each have strengths and weaknesses, which should be considered when designing experiments and drawing conclusions. Cell isolation bears the risk of artifacts that might significantly confound transcriptome-based studies, including single-cell analysis. Our study should hence caution experimentalists and make them aware of the 'observer effect' , which is well established in physics but often less appreciated in biology.
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Experimental design 1. Sample size
Describe how sample size was determined. sample sizes were chosen according to guidelines as published in NATURE METHODS | VOL.10 NO.12 . Of note, sizes of the tested animal groups were also dictated by availability of the transgenic strains and litter sizes, allowing littermate controls.
Data exclusions
Describe any data exclusions. no data were excluded from analysis
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Experiments were replicated at least once and included repeats
Randomization
Describe how samples/organisms/participants were allocated into experimental groups. Animals of the same age, sex and genetic background were randomly assigned to treatment groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigator was not blinded to the mouse group allocation. Tested samples were blindly assayed.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
